Disease severity, physical limitations and depression in HIV-infected men

Journal of Psychosomatic Research
K W GriffinJ B Williams

Abstract

Previous research has failed to identify a consistent relationship between HIV disease severity and depression. However, HIV/AIDS can lead to substantial physical limitations in those with advanced disease, which may influence mood. This study examined the extent to which HIV disease severity and physical limitations were associated with depressive symptoms in 49 HIV-infected men at the final stages of a 5-year prospective study. No differences were found in depression or quality of life among men who were asymptomatic, symptomatic, or diagnosed with AIDS. Forty-three percent of subjects reported substantial physical limitations, which were associated with higher depression scores and poorer quality of life. Degree of physical limitation predicted depression concurrently as well as depression 6 months later, after controlling for disease stage, physical symptoms, and CD4 cell counts. Findings suggest that physical limitations are more important than laboratory markers of disease progression in understanding psychological adjustment to illness in HIV-infected men.

References

Apr 1, 1992·The American Journal of Psychiatry·D F DarkoS Golshan
Apr 1, 1991·American Journal of Physical Medicine & Rehabilitation·M W O'DellF J Bonner
Jan 1, 1989·Archives of General Psychiatry·S J SchleiferM Stein
Nov 1, 1989·Journal of Child Psychology and Psychiatry, and Allied Disciplines·C Puckering
Mar 1, 1988·Journal of Health and Social Behavior·R J Turner, S Noh
Nov 1, 1988·Journal of Neurology, Neurosurgery, and Psychiatry·B E LevinW J Weiner
Jan 1, 1981·Journal of Chronic Diseases·W O SpitzerB R Catchlove
Apr 1, 1994·The American Journal of Psychiatry·S D Cochran, V M Mays
May 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·M FellM Harrison
Jun 1, 1961·Archives of General Psychiatry·A T BECKJ ERBAUGH

❮ Previous
Next ❯

Citations

Jan 20, 2006·AIDS and Behavior·Inna D RivkinDorothy Chin
Apr 13, 2006·Current HIV/AIDS Reports·Patricia DeLaMoraJoseph Stavola
Apr 29, 2000·International Journal of Nursing Studies·M Krishnasamy
Aug 13, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul M CoplanUNKNOWN AIDS Clinical Trials Group 320 Study Team
Feb 13, 2002·AIDS Patient Care and STDs·Bronwen LichtensteinJeffrey M Clair
Sep 19, 2003·AIDS Patient Care and STDs·Elise D RileyDavid R Bangsberg
Nov 18, 2006·Psychiatry and Clinical Neurosciences·Tiao-Lai HuangJien-Wei Liu
Jun 13, 2003·The Journal of the Association of Nurses in AIDS Care : JANAC·Cheryl Gore-FeltonDavid Spiegel
Dec 22, 2007·Journal of the American Medical Informatics Association : JAMIA·Tsai-Ya LaiSuzanne Bakken
Jul 23, 2002·Journal of General Internal Medicine·Amy M KilbourneMaria Rodriguez-Barradas
Jun 29, 2010·Journal of Pain and Symptom Management·Karolynn SiegelHelen-Maria Lekas
Jun 18, 2011·The American Journal on Addictions·Rachel GonzalesUNKNOWN Methamphetamine Treatment Project Corporate Authors
Mar 26, 2002·The Journal of Urology·Nan E RothrockKarl J Kreder
Mar 6, 2013·Psychology, Health & Medicine·Rogério R Zimpel, Marcelo P Fleck
Jan 22, 2003·The Australian and New Zealand Journal of Psychiatry·Angela KomitiJohn H Lloyd
Nov 6, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·C ZinkernagelUNKNOWN Swiss HIV Cohort Study
Mar 21, 2006·Issues in Mental Health Nursing·Demetrius James Porche, Danny G Willis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.